HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-linked susceptibility and resistance to Takayasu arteritis.

Abstract
To investigate genetic factors involved in the pathogenesis of Takayasu arteritis, patients in the Japanese population were examined for HLA-A, -B, and -C alleles by serological typing and for HLA-DR, DQ, and DP alleles by DNA typing using polymerase chain reaction (PCR)/sequence-specific oligonucleotide probe (SSOP) analysis. The frequencies of HLA-Bw52, DRB1*1502, DRB5*0102, DQA1*0103, DQB1*0601, and DPB1*0901 alleles were significantly increased and the frequencies of HLA-Bw54, DRB1*0405, DRB4*0101, DQA1*0301, and DQB1*0401 alleles were significantly decreased. Strong linkage disequilibria among the increased alleles and among the decreased alleles were evident in the Japanese population. Therefore, the haplotype of HLA-B252-DRB1*1502-DRB5*0102-DQA1*0103-DQB1++ +*0601-DPA1*02-DPB1*0901 may confer susceptibility to Takayasu arteritis while another haplotype of HLA-Bw54-DRB1*0405-DRB4*0101-DQA1*0301-DQB1++ +*0401 may confer resistance to the disease. These observations clearly indicate that HLA-linked gene(s) are involved in the development of Takayasu arteritis.
AuthorsR P Dong, A Kimura, F Numano, Y Nishimura, T Sasazuki
JournalHeart and vessels. Supplement (Heart Vessels Suppl) Vol. 7 Pg. 73-80 ( 1992) ISSN: 0935-736X [Print] Japan
PMID1360976 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Genetic Markers
  • HLA Antigens
  • Histocompatibility Antigens Class II
  • Oligonucleotide Probes
Topics
  • Genetic Linkage (genetics)
  • Genetic Markers (genetics)
  • HLA Antigens (genetics)
  • Histocompatibility Antigens Class II (genetics)
  • Humans
  • Oligonucleotide Probes
  • Polymerase Chain Reaction
  • Risk Factors
  • Takayasu Arteritis (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: